Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8349986 | 0.91 | POLB (0.63) | POLBTK1 | |
| SCHEMBL19101649 | 0.91 | POLB (0.66) | POLBTK1 | |
| SCHEMBL17514032 | 0.91 | POLB (0.66) | POLBTK1 | |
| SCHEMBL28399790 | 0.91 | POLB (0.66) | POLBTK1 | |
| SCHEMBL1764557 | 0.90 | TK1 (0.65) | POLBTK1 | |
| SCHEMBL7537922 | 0.89 | POLB (0.61) | POLBTK1 | |
| SCHEMBL1900391 | 0.89 | POLB (0.52) | POLBTK1 | |
| SCHEMBL8425023 | 0.89 | POLB (0.61) | POLBTK1 | |
| SCHEMBL316664 | 0.88 | POLB (0.67) | POLBTK1 | |
| SCHEMBL646741 | 0.88 | POLB (0.67) | POLBTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 680 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102666879-B | Templated nanometer conjugate | NORTHWEST UNIVERSITY (US) | 2016-02-24 | — | — | CN | claimed |
| CN-102666879-A | Templated nanoconjugates | UNIV NORTHWESTERN | 2012-09-12 | — | — | CN | claimed |
| EP-2494075-A2 | TEMPLATED NANOCONJUGATES | Northwestern University (US) | 2012-09-05 | — | — | EP | claimed |
| WO-2011053940-A2 | TEMPLATED NANOCONJUGATES | NORTHWESTERN UNIVERSITY (US) | 2011-05-05 | — | — | WO | claimed |
| WO-2008080060-A2 | 4-SE-THYMIDINE DERIVATIVES, 4-SE-URIDINE DERIVATIVES, DI (2-CYANOETHYL) DISELENIDE, AND METHODS | GEORGIA STATE UNIVERSITY (US) | 2008-07-03 | — | — | WO | claimed |
| US-12447142-B2 | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2025-10-21 | — | — | US | disclosed |
| EP-4600742-A2 | INCREASING EFFICIENCY OF PHOTOCHEMICAL REACTIONS ON SUBSTRATES | Centrillion Technologies, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250250565-A1 | OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES | ALPHA ANOMERIC SAS (FR) | 2025-08-07 | — | — | US | disclosed |
| EP-3351632-B1 | STRUCTURALLY-ENHANCED MIRNA INHIBITOR S-TUD | UNIV TOKYO (JP) | 2025-07-16 | — | — | EP | disclosed |
| US-20250205671-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | CENTRILLION TECHNOLOGIES, INC. | 2025-06-26 | — | — | US | disclosed |
| WO-2025108237-A1 | LIPID COMPOUND, NUCLEIC ACID CONJUGATE AND USE THEREOF | 施能康生物科技有限公司 | 2025-05-30 | — | — | WO | disclosed |
| CN-120025369-A | Lipid compound, nucleic acid conjugate and application thereof | 施能康生物科技有限公司 | 2025-05-23 | — | — | CN | disclosed |
| WO-1994015946-A1 | SYNTHESIS OF DIMMER BLOCKS AND THEIR USE IN ASSEMBLING OLIGONUCLEOTIDES | HYBRIDON, INC. (US) | 1994-07-21 | — | — | WO | disclosed |
| US-5252723-A | Using sulfur, non-aromatic tertiary amine and solvent, producing nucleotide multimer | GEN-PROBE, INC. (US) | 1993-10-12 | — | — | US | disclosed |
| EP-0542822-A1 | VIRAL (HIV) GROWTH INHIBITION | MEDICAL RESEARCH COUNCIL (GB) | 1993-05-26 | — | — | EP | disclosed |
| WO-1992004358-A1 | METHOD AND REAGENT FOR SULFURIZATION OF ORGANOPHOSPHOROUS COMPOUNDS | GEN-PROBE INCORPORATED (US) | 1992-03-19 | — | — | WO | disclosed |
| WO-1992002228-A1 | VIRAL (HIV) GROWTH INHIBITION | MEDICAL RESEARCH COUNCIL (GB) | 1992-02-20 | — | — | WO | disclosed |
| EP-0424819-A1 | Reversible modification of biological compounds for detection, separation and purification thereof | MILLIPORE CORPORATION (US) | 1991-05-02 | — | — | EP | disclosed |
| WO-1990011322-A2 | METHOD AND REAGENT FOR SULFURIZATION OF ORGANOPHOSPHOROUS COMPOUNDS | GEN-PROBE INCORPORATED (US) | 1990-10-04 | — | — | WO | disclosed |
| EP-0386987-A1 | Method and reagent for sulfurization of organophosphorous compounds | GEN-PROBE INCORPORATED (US) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12447142-B2 | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | CTSE, CTSB, ATG4B | POLB 600/4885TK1 1449/4885 |
| US-20250205671-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | TYR, PCNA, DNMT1 | POLB 266/4885TK1 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.